10.08.2011 • News

Symrise H1 Profit Decline

Symrise reported a drop in its first-half net income to €77.4 million from €88.8 million last year. This corresponds to earnings per share of €0.65 for the recent period versus €0.75 a year earlier.

However, in the first six months of the current financial year, Symrise posted an increase in group revenues of about 2 % to €811.8 million from €797.5 million in the previous year. The sales increase was 2.6% at local currency.

The company added that during the first half, Symrise's earnings picture was mainly affected by high raw material costs and currency effects. For 2011, Symrise said it continues to target an EBITDA margin of around 20%.

 

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read